Globex Securities projects a strong growth from Medeze Group Public Company Limited (SET: MEDEZE)...
MEDEZE Targets THB1 Billion Revenue in 2026 on ATMPs and Stem Cell Innovations
Dr. Veerapol Khemarangsan, Managing Director of Medeze Group Public Company Limited (SET: MEDEZE), revealed...
MEDEZE Targets 25% Growth for 2026, Emphasizes ATMP Innovation and Regional Expansion
Dr. Veerapol Khemarangsan, Chief Executive Officer of Medeze Group Public Company Limited (SET: MEDEZE),...
MEDEZE Forms Joint Venture for Cell Culture Media Plant with GPO and Partners
Dr. Veerapol Khemarangsan, M.D., Chief Executive Officer of Medeze Group Public Company Limited (SET:...
MEDEZE Navigates Economic Headwinds in 3Q25 with Strategic Advancement in ATMPs
MEDEZE Group Public Company Limited (SET: MEDEZE) reported a decline in profitability for the...
Medeze Achieves Compliance with National Cell Bank Certification Standards
Dr. Veerapol Khemarangsan, M.D., Chief Executive Officer of Medeze Group Public Company Limited (SET:...